CoChat

The central role of microglia in major depressive disorder and its potential as a therapeutic target

Xia, Xue, Li, Kaiqing, Zou, Wei, Wang, Long · 2025 · Frontiers in Behavioral Neuroscience
Cited by 32

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Major depressive disorder (MDD) is a complex neuropsychiatric condition whose multifactorial etiology remains incompletely explained by neuron-centric and neurotransmitter hypotheses alone. This review addresses that gap by positioning microglia—the CNS’s resident immune cells—as central drivers of MDD pathogenesis. We organize current evidence around five interrelated themes: hypothalamic–pituitary–adrenal (HPA) axis dysfunction, monoaminergic and kynurenine pathway imbalances, neuroinflammatory overactivation, synaptic and white-matter integrity disruption, and gut–brain axis perturbations. In MDD, microglia shift from a surveillant resting state to either an overactivated or functionally inhibited phenotype, exacerbating pathology via aberrant cytokine release, dysregulated synaptic pruning and impaired myelin support. These changes are modulated by genetic susceptibility, sex differences, environmental stressors and microbiome alterations. We then survey translational advances—traditional and novel therapeutics that modulate microglial polarization, emerging blood- and imaging-based biomarkers, and strategies to harness microglia–oligodendrocyte cross-talk for remyelination—and highlight integrative platforms for stratifying inflammation-driven versus non-inflammatory subtypes. Our principal takeaway is that microglia represent a unifying nexus and actionable target for precision interventions tailored to individual biological profiles.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnbeh.2025.1598178

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 171

  1. Afridi, 2023, Microglial responses to stress-induced depression: Causes and consequences., Cells, 12, 1521, 10.3390/cells12111521 · DOI
  2. Alboni, 2016, Fluoxetine treatment affects the inflammatory response and microglial function according to the quality of the living environment., Brain Behav. Immun., 58, 261, 10.1016/j.bbi.2016.07.155 · DOI · Paper page
  3. Baek, 2023, Development of a novel histone deacetylase inhibitor unveils the role of HDAC11 in alleviating depression by inhibition of microglial activation., Biomed. Pharmacother., 166, 115312, 10.1016/j.biopha.2023.115312 · DOI
  4. Bai, 2021, Gut microbiota-derived inflammation-related serum metabolites as potential biomarkers for major depressive disorder., J. Inflamm. Res., 14, 3755, 10.2147/JIR.S324922 · DOI · Paper page
  5. Bansal, 2022, Kynurenine monooxygenase inhibition and associated reduced quinolinic acid reverses depression-like behaviour by upregulating Nrf2/ARE pathway in mouse model of depression: In-vivo and In-silico studies., Neuropharmacology, 215, 109169, 10.1016/j.neuropharm.2022.109169 · DOI
  6. Bertollo, 2025, Hypothalamus-pituitary-adrenal and gut-brain axes in biological interaction pathway of the depression., Front. Neurosci., 19, 1541075, 10.3389/fnins.2025.1541075 · DOI
  7. Bian, 2021, RGFP966 is protective against lipopolysaccharide-induced depressive-like behaviors in mice by inhibiting neuroinflammation and microglial activation., Int. Immunopharmacol., 101, 108259, 10.1016/j.intimp.2021.108259 · DOI
  8. Bollinger, 2017, Behavioral stress alters corticolimbic microglia in a sex- and brain region-specific manner., PLoS One, 12, e0187631, 10.1371/journal.pone.0187631 · DOI · Paper page
  9. Böttcher, 2020, Single-cell mass cytometry of microglia in major depressive disorder reveals a non-inflammatory phenotype with increased homeostatic marker expression., Transl. Psychiatry, 10, 310, 10.1038/s41398-020-00992-2 · DOI · Paper page
  10. Brooks, 2017, Desipramine decreases expression of human and murine indoleamine-2,3-dioxygenases., Brain Behav. Immun., 62, 219, 10.1016/j.bbi.2017.02.010 · DOI
  11. Brown, 2022, Alterations in the kynurenine pathway and excitatory amino acid transporter-2 in depression with and without psychosis: Evidence of a potential astrocyte pathology., J. Psychiatr. Res., 147, 203, 10.1016/j.jpsychires.2021.12.039 · DOI
  12. Burrows, 2021, Elevated peripheral inflammation is associated with attenuated striatal reward anticipation in major depressive disorder., Brain Behav. Immun., 93, 214, 10.1016/j.bbi.2021.01.016 · DOI · Paper page
  13. Büttner, 2015, Target-based biomarker selection - Mineralocorticoid receptor-related biomarkers and treatment outcome in major depression., J. Psychiatr Res., 24, 10.1016/j.jpsychires.2015.04.012 · DOI
  14. Calabrese, 2017, Upregulation of neurotrophins by S 47445, a novel positive allosteric modulator of AMPA receptors in aged rats., Pharmacol. Res., 121, 59, 10.1016/j.phrs.2017.04.019 · DOI
  15. Carrier, 2024, Behavioral as well as hippocampal transcriptomic and microglial responses differ across sexes in adult mouse offspring exposed to a dual genetic and environmental challenge., Brain Behav. Immun., 116, 126, 10.1016/j.bbi.2023.11.025 · DOI
  16. Castellano-Gonzalez, 2019, Kynurenine 3-monooxygenase activity in human primary neurons and effect on cellular bioenergetics identifies new neurotoxic mechanisms., Neurotox Res., 35, 530, 10.1007/s12640-019-9997-4 · DOI
  17. Chaves, 2025, Activation of the Nrf2/HO-1 pathway restores N-acetylcysteine-induced impairment of the hypothalamus-pituitary-adrenal axis negative feedback by up-regulating GRα expression and down-regulating GRβ expression into pituitary glands., Front. Endocrinol., 16, 1500630, 10.3389/fendo.2025.1500630 · DOI
  18. Chen, 2024, Impacts of microbiota and its metabolites through gut-brain axis on pathophysiology of major depressive disorder., Life Sci., 351, 122815, 10.1016/j.lfs.2024.122815 · DOI
  19. Chen, 2021, Kynurenines increase MRS metabolites in basal ganglia and decrease resting-state connectivity in frontostriatal reward circuitry in depression., Transl. Psychiatry, 11, 456, 10.1038/s41398-021-01587-1 · DOI
  20. Cheng, 2024, Programmed cell death factor 4-mediated hippocampal synaptic plasticity is involved in early life stress and susceptibility to depression., Behav. Brain Res., 468, 115028, 10.1016/j.bbr.2024.115028 · DOI
  21. Cheng, 2020, Age-related atrophy of cortical thickness and genetic effect of ANK3 gene in first episode MDD patients., Neuroimage Clin., 28, 102384, 10.1016/j.nicl.2020.102384 · DOI
  22. Chung, 2012, Phenelzine (monoamine oxidase inhibitor) increases production of nitric oxide and proinflammatory cytokines via the NF-κB pathway in lipopolysaccharide-activated microglia cells., Neurochem. Res., 37, 2117, 10.1007/s11064-012-0833-y · DOI
  23. Colle, 2017, Plasma BDNF level in major depression: Biomarker of the Val66Met BDNF polymorphism and of the clinical course in met carrier patients., Neuropsychobiology, 75, 39, 10.1159/000478862 · DOI
  24. Csabai, 2018, Reduced synapse and axon numbers in the prefrontal cortex of rats subjected to a chronic stress model for depression., Front. Cell. Neurosci., 12, 24, 10.3389/fncel.2018.00024 · DOI · Paper page
  25. Dachew, 2023, Paternal depression and risk of depression among offspring: A systematic review and meta-analysis., JAMA Netw. Open, 6, e2329159, 10.1001/jamanetworkopen.2023.29159 · DOI
  26. Dicks, 2023, Our mental health is determined by an intrinsic interplay between the central nervous system. Enteric Nerves, and Gut Microbiota., Int. J. Mol. Sci., 25, 38, 10.3390/ijms25010038 · DOI
  27. Du, 2019, Microglial activation and neurobiological alterations in experimental autoimmune prostatitis-induced depressive-like behavior in mice., Neuropsychiatr. Dis. Treat., 15, 2231, 10.2147/NDT.S211288 · DOI · Paper page
  28. Du, 2023, Corticotropin-releasing hormone: A novel stimulator of somatolactin in teleost pituitary cells., Cells, 12, 2770, 10.3390/cells12242770 · DOI
  29. Edem, 2022, Ketamine abrogates sensorimotor deficits and cytokine dysregulation in a chronic unpredictable mild stress model of depression., Psychopharmacology, 239, 185, 10.1007/s00213-021-06021-4 · DOI
  30. Fan, 2025, The role of HSP90 molecular chaperones in depression: Potential mechanisms., Mol. Neurobiol., 62, 708, 10.1007/s12035-024-04284-4 · DOI
  31. Faustmann, 2023, Inhibition of microglial activation by amitriptyline and doxepin in interferon-β pre-treated astrocyte-microglia co-culture model of inflammation., Brain Sci., 13, 493, 10.3390/brainsci13030493 · DOI
  32. Feng, 2020, Mefenamic acid can attenuate depressive symptoms by suppressing microglia activation induced upon chronic stress., Brain Res., 1740, 146846, 10.1016/j.brainres.2020.146846 · DOI
  33. Feng, 2019, Glucocorticoid-driven NLRP3 inflammasome activation in hippocampal microglia mediates chronic stress-induced depressive-like behaviors., Front. Mol. Neurosci., 12, 210, 10.3389/fnmol.2019.00210 · DOI · Paper page
  34. Finley, 2018, Facilitation of hippocampal long-term potentiation and reactivation of latent HIV-1 via AMPK activation: Common mechanism of action linking learning, memory, and the potential eradication of HIV-1., Med. Hypotheses, 116, 61, 10.1016/j.mehy.2018.04.018 · DOI
  35. Fitzgerald, 2024, Microglial function interacts with the environment to affect sex-specific depression risk., Brain Behav. Immun., 119, 597, 10.1016/j.bbi.2024.04.030 · DOI
  36. Fujimori, 2015, Paroxetine prevented the down-regulation of astrocytic L-Glu transporters in neuroinflammation., J. Pharmacol. Sci., 127, 145, 10.1016/j.jphs.2014.09.002 · DOI
  37. Gałecki, 2018, The anti-inflammatory mechanism of antidepressants - SSRIs, SNRIs., Prog. Neuropsychopharmacol. Biol. Psychiatry, 80, 291, 10.1016/j.pnpbp.2017.03.016 · DOI · Paper page
  38. Gao, 2022, Serum CC chemokines as potential biomarkers for the diagnosis of major depressive disorder., Psychol. Res. Behav. Manag., 15, 2971, 10.2147/PRBM.S384267 · DOI
  39. Gargiulo-Monachelli, 2019, Comparative effects of progesterone and the synthetic progestin norethindrone on neuroprotection in a model of spontaneous motoneuron degeneration., J. Steroid. Biochem. Mol. Biol., 192, 105385, 10.1016/j.jsbmb.2019.105385 · DOI
  40. 2018, Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global burden of disease study 2017., Lancet, 392, 1789, 10.1016/S0140-6736(18)32279-7 · DOI · Paper page
  41. Green, 2024, Quantifying microglial morphology: An insight into function., Clin. Exp. Immunol., 216, 221, 10.1093/cei/uxae023 · DOI
  42. Greenshaw, 1989, Chronic effects of tranylcypromine and 4-fluorotranylcypromine on regional brain monoamine metabolism in rats: A comparison with clorgyline., Biol. Psychiatry, 25, 1014, 10.1016/0006-3223(89)90289-8 · DOI
  43. Gu, 2021, Enriched environment mitigates depressive behavior by changing the inflammatory activation phenotype of microglia in the hippocampus of depression model rats., Brain Res. Bull., 177, 252, 10.1016/j.brainresbull.2021.10.005 · DOI
  44. Guo, 2023, IGF2 inhibits hippocampal over-activated microglia and alleviates depression-like behavior in LPS- treated male mice., Brain Res. Bull., 194, 1, 10.1016/j.brainresbull.2023.01.001 · DOI
  45. Han, 2020, Lactobacillus reuteri NK33 and Bifidobacterium adolescentis NK98 Alleviate Escherichia coli- Induced depression and Gut Dysbiosis in Mice., J. Microbiol. Biotechnol., 30, 1222, 10.4014/jmb.2002.02058 · DOI
  46. Hei, 2019, Effects of chronic mild stress induced depression on synaptic plasticity in mouse hippocampus., Behav. Brain Res., 365, 26, 10.1016/j.bbr.2019.02.044 · DOI · Paper page
  47. Hell, 2016, How Ca2+-permeable AMPA receptors, the kinase PKA, and the phosphatase PP2B are intertwined in synaptic LTP and LTD., Sci. Signal, 9, e2, 10.1126/scisignal.aaf7067 · DOI
  48. Hisaoka-Nakashima, 2016, Amitriptyline induces brain-derived neurotrophic factor (BDNF) mRNA expression through ERK-dependent modulation of multiple BDNF mRNA variants in primary cultured rat cortical astrocytes and microglia., Brain Res., 1634, 57, 10.1016/j.brainres.2015.12.057 · DOI
  49. Holmes, 2018, Elevated translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking: A positron emission tomography study., Biol. Psychiatry, 83, 61, 10.1016/j.biopsych.2017.08.005 · DOI · Paper page
  50. Hong, 2024, Ethyl acetate extract of Nymphaea candida Presl: A potential anti-depressant and neuroprotective treatment strategy., Biomed. Pharmacother., 179, 117304, 10.1016/j.biopha.2024.117304 · DOI
  51. Hou, 2021, Correction to: Taurine protects noradrenergic locus coeruleus neurons in a mouse Parkinson’s disease model by inhibiting microglial M1 polarization., Amino Acids, 53, 321, 10.1007/s00726-021-02944-6 · DOI
  52. Huang, 2024, Disruption of the Na+/K+-ATPase-purinergic P2X7 receptor complex in microglia promotes stress-induced anxiety., Immunity, 57, 495, 10.1016/j.immuni.2024.01.018 · DOI
  53. Innes, 2019, Microglial-driven changes in synaptic plasticity: A possible role in major depressive disorder., Psychoneuroendocrinology, 102, 236, 10.1016/j.psyneuen.2018.12.233 · DOI · Paper page
  54. Ji, 2022, Microglial glutaminase 1 deficiency mitigates neuroinflammation associated depression., Brain Behav. Immun., 99, 231, 10.1016/j.bbi.2021.10.009 · DOI
  55. Jin, 2016, JAMA PATIENT PAGE. Screening for depression., JAMA., 315, 428, 10.1001/jama.2015.19234 · doi:10.1001/jama.2015.19234
  56. Jochems, 2014, Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability., Neuropsychopharmacology, 39, 389, 10.1038/npp.2013.207 · DOI · Paper page
  57. Joo, 2021, In Vivo cerebral translocator protein (TSPO) binding and its relationship with blood adiponectin levels in treatment-naïve young adults with major depression: A [11C]PK11195 PET study., Biomedicines, 10, 34, 10.3390/biomedicines10010034 · DOI
  58. Karlstetter, 2014, Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis., J. Neuroinflammation, 11, 3, 10.1186/1742-2094-11-3 · DOI · Paper page
  59. Kim, 2019, Anti-neuroinflammatory effects of vanillin through the regulation of Inflammatory Factors and NF-κB signaling in LPS-stimulated microglia., Appl. Biochem. Biotechnol., 187, 884, 10.1007/s12010-018-2857-5 · DOI
  60. Kitayama, 2008, Degeneration of the locus ceruleus noradrenergic neurons in the stress-induced depression of rats., Ann. N. Y. Acad. Sci., 1148, 95, 10.1196/annals.1410.059 · DOI
  61. Kleidonas, 2023, Microglia modulate TNFα-mediated synaptic plasticity., Glia, 71, 2117, 10.1002/glia.24383 · DOI
  62. Kobashi, 2020, Transplantation of M2-deviated microglia promotes recovery of motor function after spinal cord injury in mice., Mol. Ther., 28, 254, 10.1016/j.ymthe.2019.09.004 · DOI · Paper page
  63. Kracht, 2020, Human fetal microglia acquire homeostatic immune-sensing properties early in development., Science, 369, 530, 10.1126/science.aba5906 · DOI · Paper page
  64. Lechtenberg, 2019, Augmented β2-adrenergic signaling dampens the neuroinflammatory response following ischemic stroke and increases stroke size., J. Neuroinflammation, 16, 112, 10.1186/s12974-019-1506-4 · DOI
  65. Lei, 2014, Anti-inflammatory effects of progesterone in lipopolysaccharide-stimulated BV-2 microglia., PLoS One, 9, e103969, 10.1371/journal.pone.0103969 · DOI · Paper page
  66. Lewis, 2021, Microglia prune inhibitory synapses, too., Nat. Rev. Neurosci., 22, 517, 10.1038/s41583-021-00504-1 · doi:10.1038/s41583-021-00504-1
  67. Li, 2022, Stress induced microglial activation contributes to depression., Pharmacol. Res., 179, 106145, 10.1016/j.phrs.2022.106145 · DOI · Paper page
  68. Li, 2020, SNRIs achieve faster antidepressant effects than SSRIs by elevating the concentrations of dopamine in the forebrain., Neuropharmacology, 177, 108237, 10.1016/j.neuropharm.2020.108237 · DOI
  69. Li, 2019, Antidepressant-like effects of dietary gardenia blue pigment derived from genipin and tyrosine., Food Funct., 10, 4533, 10.1039/c9fo00480g · DOI
  70. Li, 2018, Antidepressant-like effects of translocator protein (18 kDa) ligand ZBD-2 in mouse models of postpartum depression., Mol. Brain, 11, 12, 10.1186/s13041-018-0355-x · DOI
  71. Li, 2022, Enriched environment priors to TET1 hippocampal administration for regulating psychiatric behaviors via glial reactivity in chronic cerebral hypoperfusion models., J. Affect. Disord., 310, 198, 10.1016/j.jad.2022.04.087 · DOI
  72. Li, 2024, Microglial Pdcd4 deficiency mitigates neuroinflammation-associated depression via facilitating Daxx mediated PPARγ/IL-10 signaling., J. Neuroinflammation, 21, 143, 10.1186/s12974-024-03142-3 · DOI
  73. Li, 2022, Sleep deprivation leads to further impairment of hippocampal synaptic plasticity by suppressing melatonin secretion in the pineal gland of chronically unpredictable stress rats., Eur. J. Pharmacol., 930, 175149, 10.1016/j.ejphar.2022.175149 · DOI
  74. Liu, 2021, ω-3 DPA protected neurons from neuroinflammation by balancing microglia M1/M2 Polarizations through Inhibiting NF-κB/MAPK p38 signaling and activating neuron-BDNF-PI3K/AKT pathways., Mar. Drugs, 19, 587, 10.3390/md19110587 · DOI · Paper page
  75. Liu, 2021, miR-146a reduces depressive behavior by inhibiting microglial activation., Mol. Med. Rep., 23, 463, 10.3892/mmr.2021.12102 · DOI
  76. Liu, 2022, Effect of Qingyangshen glycosides on social defeat mice model., J. Ethnopharmacol., 293, 115253, 10.1016/j.jep.2022.115253 · DOI
  77. Liu, 2025, Human umbilical cord mesenchymal stem cells ameliorated chronic unpredictable mild stress-induced depression and anxiety by alleviating neuroinflammation., J. Neuroimmune Pharmacol., 20, 45, 10.1007/s11481-025-10198-2 · DOI
  78. Liu, 2018, The metabolic factor kynurenic acid of kynurenine pathway predicts major depressive disorder., Front. Psychiatry, 9, 552, 10.3389/fpsyt.2018.00552 · DOI
  79. Liu, 2019, Sex differences in depressive-like behaviour may relate to imbalance of microglia activation in the hippocampus., Brain Behav. Immun., 81, 188, 10.1016/j.bbi.2019.06.012 · DOI · Paper page
  80. Liu, 2024, Running exercise alleviates hippocampal neuroinflammation and shifts the balance of microglial M1/M2 polarization through adiponectin/AdipoR1 pathway activation in mice exposed to chronic unpredictable stress., Mol. Psychiatry, 29, 2031, 10.1038/s41380-024-02464-1 · DOI
  81. Liu, 2023, The effect of Banxia-houpo decoction on CUMS-induced depression by promoting M2 microglia polarization via TrkA/Akt signalling., J. Cell. Mol. Med., 27, 3339, 10.1111/jcmm.17906 · DOI
  82. Liu, 2021, Gut microbiome composition linked to inflammatory factors and cognitive functions in first-episode, drug-naive major depressive disorder patients., Front. Neurosci., 15, 800764, 10.3389/fnins.2021.800764 · DOI
  83. Liu, 2024, Curcumol ameliorates neuroinflammation after cerebral ischemia-reperfusion injury via affecting microglial polarization and Treg/Th17 balance through Nrf2/HO-1 and NF-κB signaling., Cell Death Discov., 10, 300, 10.1038/s41420-024-02067-3 · DOI
  84. Liu, 2020, Involvement of CX3CL1/CX3CR1 in depression and cognitive impairment induced by chronic unpredictable stress and relevant underlying mechanism., Behav. Brain Res., 381, 112371, 10.1016/j.bbr.2019.112371 · DOI
  85. Liu, 2019, Glu-mGluR2/3-ERK signaling regulates apoptosis of hippocampal neurons in diabetic-depression model rats., Evid. Based Complement. Alternat. Med., 2019, 3710363, 10.1155/2019/3710363 · DOI
  86. Losenkov, 2020, Association between BDNF gene variant Rs6265 and the severity of depression in antidepressant treatment-free depressed patients., Front. Psychiatry, 11, 38, 10.3389/fpsyt.2020.00038 · DOI
  87. Lu, 2019, Sertraline ameliorates inflammation in CUMS mice and inhibits TNF-α-induced inflammation in microglia cells., Int. Immunopharmacol., 67, 119, 10.1016/j.intimp.2018.12.011 · DOI
  88. Luhong, 2024, PERK inhibitor (ISRIB) improves depression-like behavior by inhibitions of HPA-axis over-activation in mice exposed to chronic restraint stress., Behav. Brain Res., 471, 10.1016/j.bbr.2024.115122 · DOI
  89. Luo, 2025, Chronic unpredictable mild stress induces anxiety-like behavior in female C57BL/6N mice, accompanied by alterations in inflammation and the kynurenine pathway of tryptophan metabolism., Front. Neurosci., 19, 1556744, 10.3389/fnins.2025.1556744 · DOI
  90. Lynall, 2022, Genetic variants associated with psychiatric disorders are enriched at epigenetically active sites in lymphoid cells., Nat. Commun., 13, 6102, 10.1038/s41467-022-33885-7 · DOI
  91. Maggi, 1980, beta-Adrenergic regulation of alpha 2-adrenergic receptors in the central nervous system., Science, 207, 645, 10.1126/science.6101510 · DOI
  92. Maitra, 2023, Cell type specific transcriptomic differences in depression show similar patterns between males and females but implicate distinct cell types and genes., Nat. Commun., 14, 2912, 10.1038/s41467-023-38530-5 · DOI · Paper page
  93. Marx, 2021, The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: A meta-analysis of 101 studies., Mol. Psychiatry, 26, 4158, 10.1038/s41380-020-00951-9 · DOI · Paper page
  94. Marx, 2023, Major depressive disorder., Nat. Rev. Dis. Primers, 9, 44, 10.1038/s41572-023-00454-1 · DOI · Paper page
  95. Morris, 2020, The role of the locus coeruleus in the generation of pathological anxiety., Brain Neurosci. Adv., 4, 2398212820930321, 10.1177/2398212820930321 · DOI · Paper page
  96. Nakatani, 2022, Duloxetine ameliorates lipopolysaccharide-induced microglial activation by suppressing iNOS expression in BV-2 microglial cells., Psychopharmacology, 239, 3133, 10.1007/s00213-022-06194-6 · DOI
  97. Nelson, 2019, Small cells with big implications: Microglia and sex differences in brain development, plasticity and behavioral health., Prog. Neurobiol., 176, 103, 10.1016/j.pneurobio.2018.09.002 · DOI
  98. Newell, 1997, Glycine causes increased excitability and neurotoxicity by activation of NMDA receptors in the hippocampus., Exp. Neurol., 145, 235, 10.1006/exnr.1997.6463 · DOI
  99. Nikolova, 2023, Acceptability, tolerability, and estimates of putative treatment effects of probiotics as adjunctive treatment in patients with depression: A randomized clinical trial., JAMA Psychiatry, 80, 842, 10.1001/jamapsychiatry.2023.1817 · DOI · Paper page
  100. Nissen, 2017, Microglial function across the spectrum of age and gender., Int. J. Mol. Sci., 18, 561, 10.3390/ijms18030561 · DOI · Paper page
  101. Norden, 2015, Fluoxetine prevents the development of depressive-like behavior in a mouse model of cancer related fatigue., Physiol. Behav., 140, 230, 10.1016/j.physbeh.2014.12.045 · DOI · Paper page
  102. Oxenkrug, 2010, Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: The serotonin hypothesis revisited 40 years later., Isr. J. Psychiatry Relat. Sci., 47, 56
  103. Pandey, 2013, Region-specific alterations in glucocorticoid receptor expression in the postmortem brain of teenage suicide victims., Psychoneuroendocrinology, 38, 2628, 10.1016/j.psyneuen.2013.06.020 · DOI
  104. Park, 2020, Chronically infused angiotensin II induces depressive-like behavior via microglia activation., Sci. Rep., 10, 22082, 10.1038/s41598-020-79096-2 · DOI
  105. Peles, 2023, Glucocorticoid-sensitive period of corticotroph development-Implications for mechanisms of early life stress., J. Neuroendocrinol., 35, e13229, 10.1111/jne.13229 · DOI
  106. Peng, 2021, Dlg1 knockout inhibits microglial activation and alleviates lipopolysaccharide-induced depression-like behavior in mice., Neurosci. Bull., 37, 1671, 10.1007/s12264-021-00765-x · DOI
  107. Pezawas, 2008, Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression., Mol. Psychiatry, 13, 709, 10.1038/mp.2008.32 · DOI · Paper page
  108. Pilmeyer, 2024, Improved clinical outcome prediction in depression using neurodynamics in an emotional face-matching functional MRI task., Front. Psychiatry, 15, 1255370, 10.3389/fpsyt.2024.1255370 · DOI
  109. Pišlar, 2022, Cysteine peptidase Cathepsin X as a therapeutic target for simultaneous TLR3/4-mediated microglia activation., Mol. Neurobiol., 59, 2258, 10.1007/s12035-021-02694-2 · DOI
  110. Pohl, 2021, Microglia react to partner loss in a sex- and brain site-specific manner in prairie voles., Brain Behav. Immun., 96, 168, 10.1016/j.bbi.2021.05.026 · DOI
  111. Pozzo Tremolanti, 2019, Microglial pro-inflammatory and anti-inflammatory phenotypes are modulated by translocator protein activation., Int. J. Mol. Sci., 20, 4467, 10.3390/ijms20184467 · DOI · Paper page
  112. Prodan-Bărbulescu, 2024, Identification of specific plasma miRNAs as potential biomarkers for major depressive disorder., Biomedicines, 12, 2165, 10.3390/biomedicines12102165 · DOI
  113. Ramirez, 2016, Antidepressant imipramine diminishes stress-induced inflammation in the periphery and central nervous system and related anxiety- and depressive- like behaviors., Brain Behav. Immun., 57, 293, 10.1016/j.bbi.2016.05.008 · DOI · Paper page
  114. Reichert Plaska, 2024, Evidence for reduced anti-inflammatory microglial phagocytic response in late-life major depression., Brain Behav. Immun., 120, 248, 10.1016/j.bbi.2024.05.030 · DOI
  115. Rial, 2015, Depression as a glial-based synaptic dysfunction., Front. Cell. Neurosci., 9, 521, 10.3389/fncel.2015.00521 · DOI · Paper page
  116. Richards, 2018, PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects., EJNMMI Res., 8, 57, 10.1186/s13550-018-0401-9 · DOI · Paper page
  117. Ruiz, 2022, Inflammatory process and immune system in major depressive disorder., Int. J. Neuropsychopharmacol., 25, 46, 10.1093/ijnp/pyab072 · DOI
  118. Santamaría, 1996, Systemic DL-kynurenine and probenecid pretreatment attenuates quinolinic acid-induced neurotoxicity in rats., Neuropharmacology, 35, 23, 10.1016/0028-3908(95)00145-x · DOI
  119. Schmitz, 2025, Functional resting state connectivity is differentially associated with IL-6 and TNF-α in depression and in healthy controls., Sci. Rep., 15, 1769, 10.1038/s41598-025-85514-0 · DOI
  120. Shi, 2021, Hypothesis of gender differences in self-reporting symptom of depression: Implications to solve under-diagnosis and under-treatment of depression in males., Front. Psychiatry, 12, 589687, 10.3389/fpsyt.2021.589687 · DOI · Paper page
  121. Singh, 2024, Pituitary adenylyl cyclase-activating polypeptide modulates the stress response: The involvement of different brain areas and microglia., Front. Psychiatry, 15, 1495598, 10.3389/fpsyt.2024.1495598 · DOI
  122. Slavova, 2024, Role of the locus coeruleus-noradrenergic system in stress-related psychopathology and resilience: Clinical and pre-clinical evidences., Neurosci. Biobehav. Rev., 167, 105925, 10.1016/j.neubiorev.2024.105925 · DOI
  123. Ślusarczyk, 2018, Targeting the NLRP3 inflammasome-related pathways via tianeptine treatment-suppressed microglia polarization to the M1 Phenotype in lipopolysaccharide-stimulated cultures., Int. J. Mol. Sci., 19, 1965, 10.3390/ijms19071965 · DOI · Paper page
  124. Song, 2022, Microglial-oligodendrocyte interactions in myelination and neurological function recovery after traumatic brain injury., J. Neuroinflammation, 19, 246, 10.1186/s12974-022-02608-6 · DOI
  125. Stagni, 2017, A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS., Exp. Neurol., 298, 79, 10.1016/j.expneurol.2017.08.018 · DOI
  126. Stowell, 2019, Noradrenergic signaling in the wakeful state inhibits microglial surveillance and synaptic plasticity in the mouse visual cortex., Nat. Neurosci., 22, 1782, 10.1038/s41593-019-0514-0 · DOI · Paper page
  127. Su, 2015, Fluoxetine and S-citalopram inhibit M1 activation and promote M2 activation of microglia in vitro., Neuroscience, 294, 60, 10.1016/j.neuroscience.2015.02.028 · DOI
  128. Sugama, 2019, Stress-induced microglial activation occurs through β-adrenergic receptor: Noradrenaline as a key neurotransmitter in microglial activation., J. Neuroinflammation, 16, 10.1186/s12974-019-1632-z · DOI
  129. Terrillion, 2017, Reduced levels of Cacna1c attenuate mesolimbic dopamine system function., Genes Brain Behav., 16, 495, 10.1111/gbb.12371 · DOI
  130. Tian, 2019, Clostridium butyricum miyairi 588 has preventive effects on chronic social defeat stress-induced depressive-like behaviour and modulates microglial activation in mice., Biochem. Biophys. Res. Commun., 516, 430, 10.1016/j.bbrc.2019.06.053 · DOI · Paper page
  131. Valenza, 2024, Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD., Transl. Psychiatry, 14, 209, 10.1038/s41398-024-02928-6 · DOI
  132. Wang, 2018, HMGB1 mediates depressive behavior induced by chronic stress through activating the kynurenine pathway., Brain Behav. Immun., 72, 51, 10.1016/j.bbi.2017.11.017 · DOI
  133. Wang, 2017, Effects of α2A adrenoceptors on norepinephrine secretion from the locus coeruleus during chronic stress-induced depression., Front. Neurosci., 11, 243, 10.3389/fnins.2017.00243 · DOI
  134. Wang, 2021, Microglia heterogeneity in Alzheimer’s disease: Insights from single-cell technologies., Front. Synaptic. Neurosci., 13, 773590, 10.3389/fnsyn.2021.773590 · DOI
  135. Wang, 2022, Microglia in depression: An overview of microglia in the pathogenesis and treatment of depression., J. Neuroinflammation, 19, 132, 10.1186/s12974-022-02492-0 · DOI · Paper page
  136. Wang, 2024, Gut microbiota contributes to the intestinal and extraintestinal immune homeostasis by balancing Th17/Treg cells., Int. Immunopharmacol., 143, 113570, 10.1016/j.intimp.2024.113570 · DOI
  137. Wang, 2022, The protective effect of Palmatine on depressive like behavior by modulating microglia polarization in LPS-induced mice., Neurochem. Res., 47, 3178, 10.1007/s11064-022-03672-3 · DOI
  138. Wang, 2023, Saikosaponin B2 ameliorates depression-induced microglia activation by inhibiting ferroptosis-mediated neuroinflammation and ER stress., J. Ethnopharmacol., 316, 116729, 10.1016/j.jep.2023.116729 · DOI
  139. Wei, 2002, Propofol facilitates the development of long-term depression (LTD) and impairs the maintenance of long-term potentiation (LTP) in the CA1 region of the hippocampus of anesthetized rats., Neurosci. Lett., 324, 181, 10.1016/s0304-3940(02)00183-0 · DOI
  140. Wu, 2024, Depression and metabolic connectivity: Insights into the locus coeruleus, HF-rTMS, and anxiety., Transl. Psychiatry, 14, 459, 10.1038/s41398-024-03171-9 · DOI
  141. Wu, 2023, White matter microstructure changes in adults with major depressive disorder: Evidence from diffusion magnetic resonance imaging., BJPsych Open, 9, e101, 10.1192/bjo.2023.30 · DOI
  142. Wu, 2022, Ketamine regulates the autophagy flux and polarization of microglia through the HMGB1-RAGE axis and exerts antidepressant effects in mice., J. Neuropathol. Exp. Neurol., 81, 931, 10.1093/jnen/nlac035 · DOI
  143. Wu, 2022, Involvement of kynurenine pathway between inflammation and glutamate in the underlying etiopathology of CUMS-induced depression mouse model., BMC Neurosci., 23, 62, 10.1186/s12868-022-00746-4 · DOI
  144. Xia, 2022, The comparison of sex differences in depression-like behaviors and neuroinflammatory changes in a rat model of depression induced by chronic stress., Front. Behav. Neurosci., 16, 1059594, 10.3389/fnbeh.2022.1059594 · DOI
  145. Xiao, 2022, Knockdown of FSTL1 inhibits microglia activation and alleviates depressive-like symptoms through modulating TLR4/MyD88/NF-κB pathway in CUMS mice., Exp. Neurol., 353, 114060, 10.1016/j.expneurol.2022.114060 · DOI
  146. Xie, 2025, Corticosterone-induced postpartum depression induces depression-like behavior and impairs hippocampal neurogenesis in adolescent offspring via HPA axis and BDNF-mTOR pathway., Neurobiol. Stress, 34, 100708, 10.1016/j.ynstr.2025.100708 · DOI
  147. Xie, 2021, Inhibition of phosphodiesterase-4 suppresses HMGB1/RAGE signaling pathway and NLRP3 inflammasome activation in mice exposed to chronic unpredictable mild stress., Brain Behav. Immun., 92, 67, 10.1016/j.bbi.2020.11.029 · DOI
  148. Xu, 2018, Hippocampal mTOR signaling is required for the antidepressant effects of paroxetine., Neuropharmacology, 128, 181, 10.1016/j.neuropharm.2017.10.008 · DOI
  149. Xu, 2023, Potential value of Interleukin-6 as a diagnostic biomarker in human MDD and the antidepressant effect of its receptor antagonist tocilizumab in lipopolysaccharide-challenged rats., Int. Immunopharmacol., 124, 110903, 10.1016/j.intimp.2023.110903 · DOI
  150. Xu, 2021, Activation of liver X receptors prevents emotional and cognitive dysfunction by suppressing microglial M1-polarization and restoring synaptic plasticity in the hippocampus of mice., Brain Behav. Immun., 94, 111, 10.1016/j.bbi.2021.02.026 · DOI · Paper page
  151. Xu, 2018, Nesfatin-1 and cortisol: Potential novel diagnostic biomarkers in moderate and severe depressive disorder., Psychol. Res. Behav Manag., 11, 495, 10.2147/PRBM.S183126 · DOI
  152. Yang, 2024, The role of the toll like receptor 4 signaling in sex-specific persistency of depression-like behavior in response to chronic stress., Brain Behav. Immun., 115, 169, 10.1016/j.bbi.2023.10.006 · DOI
  153. Yao, 2025, Kai-Xin-San ameliorates fluoxetine-resistant depressive-like behaviors by modulating tryptophan-kynurenine metabolic homeostasis in a rodent model., J. Ethnopharmacol., 351, 120011, 10.1016/j.jep.2025.120011 · DOI
  154. Yilmaz, 2019, Neurosteroids as regulators of neuroinflammation., Front. Neuroendocrinol., 55, 100788, 10.1016/j.yfrne.2019.100788 · DOI · Paper page
  155. Yu, 2020, Impaired LTD-like motor cortical plasticity in female patients with major depression disorder., Neuropharmacology, 179, 108268, 10.1016/j.neuropharm.2020.108268 · DOI
  156. Yu, 2023, Lipopolysaccharide preconditioning restricts microglial overactivation and alleviates inflammation-induced depressive-like behavior in mice., Brain Sci., 13, 549, 10.3390/brainsci13040549 · DOI
  157. Zhang, 2016, Propofol alleviates electroconvulsive shock-induced memory impairment by modulating proBDNF/mBDNF ratio in depressive rats., Brain Res., 1642, 43, 10.1016/j.brainres.2016.03.020 · DOI
  158. Zhang, 2021, Cang-ai volatile oil ameliorates depressive behavior induced by chronic stress through IDO-mediated tryptophan degradation pathway., Front. Psychiatry, 12, 791991, 10.3389/fpsyt.2021.791991 · DOI
  159. Zhang, 2023, Matrine alleviates depressive-like behaviors via modulating microbiota-gut-brain axis in CUMS-induced mice., J. Transl. Med., 21, 145, 10.1186/s12967-023-03993-z · DOI
  160. Zhang, 2024, Navigating the complex terrain of dysregulated microglial function in depressive disorders: Insights, challenges and future directions., Aging Dis., 16, 1023, 10.14336/AD.2024.0326 · DOI
  161. Zhao, 2022, Dopamine receptors: Is it possible to become a therapeutic target for depression?, Front. Pharmacol., 13, 947785, 10.3389/fphar.2022.947785 · DOI
  162. Zhao, 2022, A pilot exploration of multi-omics research of gut microbiome in major depressive disorders., Transl. Psychiatry, 12, 8, 10.1038/s41398-021-01769-x · DOI
  163. Zhao, 2019, CACNA1C rs1006737, threatening life events, and gene-environment interaction predict major depressive disorder., Front. Psychiatry, 10, 982, 10.3389/fpsyt.2019.00982 · DOI
  164. Zhao, 2023, BDNF gene hydroxymethylation in hippocampus related to neuroinflammation-induced depression-like behaviors in mice., J. Affect. Disord., 323, 723, 10.1016/j.jad.2022.12.035 · DOI
  165. Zhao, 2017, Activation of ATP-sensitive potassium channel by iptakalim normalizes stress-induced HPA axis disorder and depressive behaviour by alleviating inflammation and oxidative stress in mouse hypothalamus., Brain Res. Bull., 130, 146, 10.1016/j.brainresbull.2017.01.026 · DOI
  166. Zheng, 2018, The dynamic characteristics of the anterior cingulate cortex in resting-state fMRI of patients with depression., J. Affect. Disord., 227, 391, 10.1016/j.jad.2017.11.026 · DOI
  167. Zheng, 2024, Effects of acupuncture on hypothalamic-pituitary-adrenal axis: Current status and future perspectives., J. Integr. Med., 22, 445, 10.1016/j.joim.2024.06.004 · DOI
  168. Zhou, 2024, Cynaroside improved depressive-like behavior in CUMS mice by suppressing microglial inflammation and ferroptosis., Biomed. Pharmacother., 173, 116425, 10.1016/j.biopha.2024.116425 · DOI
  169. Zhu, 2024, Apoptosis-induced decline in hippocampal microglia mediates the development of depression-like behaviors in adult mice triggered by unpredictable stress during adolescence., Eur. J. Pharmacol., 978, 176763, 10.1016/j.ejphar.2024.176763 · DOI
  170. Zhvania, 2024, Propionic acid affects the synaptic architecture of rat hippocampus and prefrontal cortex., Micron, 181, 103624, 10.1016/j.micron.2024.103624 · DOI
  171. Zou, 2017, Novel Phosphodiesterase 4 inhibitor FCPR03 alleviates lipopolysaccharide-induced neuroinflammation by regulation of the cAMP/PKA/CREB signaling pathway and NF- κ B inhibition., J. Pharmacol. Exp. Ther., 362, 67, 10.1124/jpet.116.239608 · DOI

Metadata

Authors
Xia, X., Li, K., Zou, W., & Wang, L.
Venue
Frontiers in Behavioral Neuroscience
Published
2025-08-11
Volume
19
ISSN
1662-5153
Cited by
32
References
32

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.